Transpact Enterprises Limited Stock

Equities

TRANSPACT

INE06YD01010

Advanced Medical Equipment & Technology

Delayed Bombay S.E. 06:00:53 2024-04-19 am EDT 5-day change 1st Jan Change
361 INR -5.00% Intraday chart for Transpact Enterprises Limited -.--% -6.23%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2022 1.5 125.18 Sales 2023 3.82 319.2 Capitalization 36.74M 3.07B
Net income 2022 -2M -167M Net income 2023 - 0 EV / Sales 2022 40,057,373 x
Net Debt 2022 2.73M 228M Net Debt 2023 2.65M 221M EV / Sales 2023 10,297,346 x
P/E ratio 2022
-26 x
P/E ratio 2023
-55.8 x
Employees 8
Yield 2022 *
-
Yield 2023
-
Free-Float 37.34%
More Fundamentals * Assessed data
Dynamic Chart
Transpact Enterprises Limited Approves Appointment of Ms. Amrita Gupta as the Company Secretary and Compliance Officer CI
Transpact Enterprises Limited Announces Resignation of Damini Baid as Woman Additional Independent Director CI
Transpact Enterprises Limited Announces Resignation of Puneet Vaidya as Company Secretary CI
Transpact Enterprises Limited Announces Board Changes CI
Transpact Enterprises Limited Announces Resignation of Shariq Nisar from Non-Executive Independent Director CI
Transpact Enterprises Limited Announces Cessation of Aslam Khan as Managing Director CI
Transpact Enterprises Limited Announces Resignation of Aslam Khan from Board CI
Transpact Enterprises Limited Announces Director Resignations CI
Transpact Enterprises Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Transpact Enterprises Limited Appoints Puneet Vaidya as the Company Secretary and Compliance Officer CI
Transpact Enterprises Limited Announces Resignation of Viraj Mane as Company Secretary and Compliance Officer CI
Raman Talwar and Kaushik Waghela entered into a sale purchase agreement to acquire 32.2% stake in Transpact Enterprises Limited from Aslam Khan for INR 16.8 million. CI
Raman Talwar and Kaushik Waghela made an offer to acquire 26% stake in Transpact Enterprises Limited for INR 14.1 million. CI
77,500 Equity Shares of Transpact Enterprises Limited are subject to a Lock-Up Agreement Ending on 10-SEP-2022. CI
Transpact Enterprises Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
More news
1 day-5.00%
1 month-9.75%
3 months-12.99%
6 months+29.86%
Current year-6.23%
More quotes
1 month
361.00
Extreme 361
361.00
Current year
361.00
Extreme 361
483.80
1 year
120.40
Extreme 120.4
483.80
3 years
86.00
Extreme 86
483.80
5 years
86.00
Extreme 86
483.80
10 years
86.00
Extreme 86
483.80
More quotes
Managers TitleAgeSince
Founder - 12-12-31
Founder 53 13-05-12
Director of Finance/CFO - 19-04-17
Members of the board TitleAgeSince
Founder 53 13-05-12
Director/Board Member 42 23-08-31
Director/Board Member 36 23-08-31
More insiders
Transpact Enterprises Ltd is engaged in design, development, manufacturing, and distribution of therapeutic devices and rehabilitations services with analytics and management software system. The Company’s products include Vestibulator Chair, Vestibulator and RehabSoft. Vestibulator Chair is an ergonomically designed compact vestibular therapy device for at home therapy of children suffering from vestibular dysfunction and developmental disorders. Vestibulator is a compact, mechanized, therapeutic healthcare device, which is ergonomically designed to provide stimulation for vestibular, neuro-developmental, and sensory integration therapy. RehabSoft is a cloud-based therapy and rehabilitation software solution developed to streamline and manage the therapy, rehab clinical documentation, nutrition schedule, administrative processes, and training and individual education plan.
More about the company
  1. Stock Market
  2. Equities
  3. TRANSPACT Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW